Dashboard
Manage Tickers

CNTXContext Therapeutics Inc.

Nasdaq contexttherapeutics.com


$ 2.51 $ -0.10 (-3.83 %)    

Monday, 19-Aug-2024 15:20:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.56 $ 3.90 (0.82 %)
DIA $ 408.48 $ 1.05 (0.26 %)
SPY $ 558.23 $ 3.34 (0.6 %)
TLT $ 97.93 $ -0.01 (-0.01 %)
GLD $ 231.54 $ 1.34 (0.58 %)
$ 2.61
$ 2.60
$ 2.51 x 100
$ 2.52 x 100
$ 2.50 - $ 2.63
$ 0.77 - $ 2.75
88,749
na
143.44M
$ 1.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-22-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-23-2022 12-31-2021 10-K
12 12-02-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

context-therapeutics-q2-2024-adj-eps-004-beats-007-estimate
Context Therapeutics Q2 2024 Adj EPS $(0.0...
08/07/2024 21:26:54

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of ...

hc-wainwright--co-reiterates-buy-on-context-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Cont...
07/10/2024 17:13:37

HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $5 price...

context-therapeutics-acquires-phase-1-ready-t-cell-engager-ct-95-formerly-owned-by-link-immunotherapeutics-no-terms-disclosed
Context Therapeutics Acquires Phase 1-Read...
07/10/2024 11:33:08

CT-95, formerly owned by Link Immunotherapeutics, a mesothelin x CD3 T cell engaging bispecific antibody with first-in-class po...

context-therapeutics-13g-filing-shows-great-point-partners-llc-reported-a-989-stake-in-the-co-as-of-may-31-2024
Context Therapeutics 13G Filing Shows Grea...
06/05/2024 14:48:55

- SEC Filing

piper-sandler-initiates-coverage-on-context-therapeutics-with-overweight-rating-announces-price-target-of-45
Piper Sandler Initiates Coverage On Contex...
05/16/2024 09:40:56

Piper Sandler analyst Joseph Catanzaro initiates coverage on Context Therapeutics (NASDAQ:CNTX) with a Overweight rating and...

context-therapeutics-13g-filing-shows- avidity-partners-management-lp-reported-a-99-stake-in-the-co-as-of-may-2-2024
Context Therapeutics 13G Filing Shows Avi...
05/13/2024 14:43:49

- SEC Filing

deep-track-capital-reports-passive-stake-of-989-in-context-therapeutics-as-of-may-2-2024
Deep Track Capital Reports Passive Stake O...
05/10/2024 20:24:53

-SEC Filing

hc-wainwright--co-maintains-buy-on-context-therapeutics-raises-price-target-to-5
HC Wainwright & Co. Maintains Buy on Conte...
05/09/2024 19:29:43

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and raises the price ta...

maxim-group-maintains-buy-on-context-therapeutics-raises-price-target-to-10
Maxim Group Maintains Buy on Context Thera...
05/09/2024 17:10:11

Maxim Group analyst Jason McCarthy maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and raises the price target from ...

context-therapeutics-q1-eps-023-beats-038-estimate
Context Therapeutics Q1 EPS $(0.23) Beats ...
05/08/2024 22:00:36

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 12:06:20

context-therapeutics-announces-100m-private-placement-proceeds-along-with-existing-cash-and-cash-equivalents-are-expected-to-extend-cash-runway-into-2028
Context Therapeutics Announces $100M Priva...
05/02/2024 12:28:46

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 12:06:54

context-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1-clinical-trial-of-ctim-76
Context Therapeutics Announces FDA Clearan...
05/02/2024 11:34:23

context-therapeutics-submitted-an-fda-investigational-new-drug-to-begin-phase-1-dose-escalation-and-expansion-trial-of-ctim-76-for-claudin-6-positive-gynecologic-and-testicular-cancers
Context Therapeutics Submitted An FDA Inve...
04/01/2024 11:46:54

hc-wainwright--co-maintains-buy-on-context-therapeutics-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Conte...
03/21/2024 16:21:13

HC Wainwright & Co. analyst Emily Bodnar maintains Context Therapeutics (NASDAQ:CNTX) with a Buy and lowers the price ta...

context-therapeutics-reported-fy23-eps-loss-of-150-vs-093-yoy-cash-balance-of-144m
Context Therapeutics Reported FY23 EPS Los...
03/21/2024 11:49:40

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
01/12/2024 21:31:10

why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Quanex Building Products Shares Are Tr...
12/15/2023 17:46:24

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
12/15/2023 17:31:25

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION